Lv1
48 积分 2024-10-20 加入
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
Genetics of Chronic Kidney Disease
11个月前
已完结
Chronic kidney disease
11个月前
已完结
Disease burden and unmet medical needs in Chinese patients with moderate-to-severe psoriasis: a systematic review
1年前
已完结
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis
1年前
已完结
皖公网安备34019202002308
